The US president said he would hit copper and drug imports with 50% and 200% tariffs respectively. It may not happen. But indiscriminately wielding the same hammer at commodities and consumer goods ...

Cheng was a pioneer in clinical trials for tumour diseases, especially small-cell lung carcinoma A top Chinese oncologist and physician-scientist, Cheng Ying, has died suddenly aged 62, according to ...

The Lancet on the anti-IL-5 antibody mepolizumab in individuals with allergic asthma, evidence has accumulated that the pathogenetic role of eosinophils is fundamentally different between asthma ...

London has struggled for several years to attract big-name IPOs amid a dearth of liquidity and a less favourable regulatory ...

Gilt yields spike on Reeves exit speculation and CEO of AstraZeneca discusses leaving London - Stock markets updates and business news from Wednesday ...

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate ...

As the UK market grapples with the repercussions of faltering trade data from China, the FTSE 100 and FTSE 250 indices have experienced declines, reflecting broader global economic concerns. In such a ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

Find the latest AstraZeneca Pharma India Limited (ASTRAZEN.NS) stock quote, history, news and other vital information to help you with your stock trading and investing.

AstraZeneca takes action to drive sustainability With an increase in ageing populations, a rising burden of chronic disease, and the growing impact of the climate crisis on health, health systems ...

Cambridge-based AstraZeneca looks like it has set another drug on its way to blockbuster status - Datroway for the treatment of lung cancer. Datroway has just been approved in the US for patients with ...